GEROSCIENCE TRANSLATIONAL CLINICAL TRIALS /
ICFSR (FRAILTY AND SARCOPENIA) TASK FORCE

 

Translational Research on Mitochondria Aging Muscle, Sarcopenia and Frailty: from Biological Assessment to Drug Development

&

Patient-Reported Outcomes in Frailty and Sarcopenia

 

DISCOVER THE PRELIMINARY PROGRAM HERE

 


 

 

 

The Task Force is open to additional communications; if you have any interest in presenting your work, please submit your abstract along with your CV as soon as possible and before January 4, 2024 by clicking HERE

 

This Task Force is limited to a small number of Key Opinion Leaders (maximum of 80 persons) from academy and industry to allow for productive discussions on the development of new drugs for healthy aging.

 

 


 

 

 

Read our 2023 Task Force publications 

 

Looking at frailty and intrinsic capacity through a geroscience lens: the ICFSR & Geroscience Task Force Nature Aging read the article HERE

 

Challenges in Developing Geroscience Trials published in Nature Communications read the article HERE 

 

 

 

 

 

 

 

 

 

 

Copyright © key4events - All rights reserved